GABRG2 mutations may lead to SHE pathogenicity by reducing synaptic expression and receptor clustering, resulting in channel dysfunction and GABAergic transmission impairment within cortical circuits. This evidence concerns the gene GABRG2 and sleep-related hypermotor epilepsy.